文献速递头颈技术与安全PETCTUS

F-18 氟胆碱 PET/CT 在甲状旁腺激素升高且传统影像阴性或不一致患者中检测功能亢进甲状旁腺组织的表现

Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging.
PubMed 文献 · Korean J Radiol · 2020-01-01

回顾性分析 105 例甲状旁腺功能亢进患者,评估 F-18 氟胆碱 PET/CT 检测功能亢进甲状旁腺组织(HPT)的诊断性能,并与锝-99m 甲氧异腈闪烁显像和颈部超声比较。FCH PET/CT 敏感度 94.1%(95/101)、阳性预测值 97.9%(95/97)、准确率 92.4%(97/105),均高于 MIBI 闪烁显像和超声;在 MIBI 和超声均阴性的 35 例患者中,30 例(86%)FCH PET/CT 阳性。结论认为 FCH PET/CT 是检测 HPT 的有效影像方法,在现有影像技术中敏感度最高,可推荐用于传统影像阴性或不 conclusive 的患者。

要点

  • FCH PET/CT 检测 HPT 的敏感度为 94.1%(95/101),阳性预测值 97.9%(95/97),准确率 92.4%(97/105)。
  • MIBI 闪烁显像和颈部超声均阴性的 35 例患者中,30 例(86%)FCH PET/CT 显示阳性。
  • FCH PET/CT 在 11 例患者中显示 HPT 异位位置,而 MIBI 和超声分别仅 6 例和 3 例显示阳性。

核心结论

  • FCH PET/CT 是检测 HPT 的有效影像方法,在现有影像技术中敏感度最高,可推荐用于传统影像阴性或结果不一致的患者。

研究设计与样本

  • 回顾性分析 105 例甲状旁腺功能亢进患者的 FCH PET/CT、双时相 MIBI 甲状旁腺闪烁显像(中位间隔 42 天)和颈部超声图像;金标准为 81 例接受甲状旁腺切除术患者的组织病理学结果,其余 24 例为临床随访结果。

诊断标准与关键数值

  • FCH PET/CT 检测 HPT 的敏感度 94.1%(95/101)、阳性预测值 97.9%(95/97)、准确率 92.4%(97/105)。
  • MIBI 闪烁显像检测 HPT 的敏感度 45.1%(46/102)、阳性预测值 97.9%(46/47)、准确率 45.7%(48/105)。
  • 颈部超声检测 HPT 的敏感度 44.1%(45/102)、阳性预测值 93.8%(45/48)、准确率 42.9%(45/105)。
  • FCH PET/CT 检测 HPT 的敏感度显著高于 MIBI 闪烁显像和超声(p < 0.01)。

临床应用与阅片要点

  • 在甲状旁腺激素升高且传统影像阴性或结果不一致的患者中,FCH PET/CT 可提供较高的 HPT 检出敏感度。
  • MIBI 闪烁显像和颈部超声均阴性的患者中,86%(30/35)FCH PET/CT 显示阳性,提示 FCH PET/CT 可补充传统影像的不足。
  • FCH PET/CT 有助于显示 HPT 的异位位置(11 例),而 MIBI 和超声分别仅显示 6 例和 3 例。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Our aim was to assess the diagnostic performance of F-18 fluorocholine (FCH) positron emission tomography/computed tomography (PET/CT) in detecting hyperfunctioning parathyroid tissue (HPT) in patients with elevated parathyroid hormone levels with negative or inconclusive conventional imaging results and to compare the findings with those obtained using technetium-99m sestamibi (MIBI) scintigraphy and neck ultrasonography (US).

MATERIALS AND METHODS: Images of 105 patients with hyperparathyroidism who underwent FCH PET/CT, dual-phase MIBI parathyroid scintigraphy (median interval: 42 days), and neck US were retrospectively analyzed. The gold standard was histopathological findings for 81 patients who underwent parathyroidectomy and clinical follow-up findings in the remaining 24 patients. Sensitivities, positive predictive values (PPVs), and accuracies were calculated for all imaging modalities.

RESULTS: Among the 81 patients who underwent parathyroidectomy, either parathyroid adenoma (n = 64), hyperplasia (n = 9), neoplasia (n = 4), or both parathyroid adenoma and hyperplasia (n = 1) were detected, except 3 patients who did not show HPT. Of the 24 (23%) patients who were followed-up without operation, 22 (92%) showed persistent hyperparathyroidism. FCH PET/CT showed significantly higher sensitivity than MIBI scintigraphy and US in detection of HPT (p < 0.01). Sensitivity, PPV, and accuracy of FCH PET/CT were 94.1% (95/101), 97.9% (95/97), and 92.4% (97/105), respectively. The corresponding values for MIBI scintigraphy and US were 45.1% (46/102), 97.9% (46/47), and 45.7% (48/105) and 44.1% (45/102), 93.8% (45/48), and 42.9% (45/105), respectively. Among the 35 patients showing negative MIBI scintigraphy and neck US findings, 30 (86%) showed positive results on FCH PET/CT. FCH PET/CT could demonstrate ectopic locations of HPT in 11 patients whereas MIBI and US showed positive findings in only 6 and 3 patients, respectively.

CONCLUSION: FCH PET/CT is an effective imaging modality for detection of HPT with the highest sensitivity among the available imaging techniques. Therefore, FCH PET/CT can be recommended especially for patients who show negative or inconclusive results on conventional imaging.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Uslu-Beşli L, Sonmezoglu K, Teksoz S, et al. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging. Korean J Radiol. 2020. PMID: 31997599. doi:10.3348/kjr.2019.0268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。